Skip to content
Nonprofiteer
← DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC

Form 990 for tax year 2023

Filed by DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC.

Totals

Total revenue
$0
Total expenses
$250,724
Contributions and grants received
$0
Grants paid
$0
Program service revenue
$0
Investment income
$0
Other revenue
$0
Total assets, end of year
$0
Total liabilities, end of year
$0
Net assets or fund balances, end of year
$0
Program services expenses (Part IX)
$250,724
Management and general expenses
$0
Fundraising expenses
$0
Program service expenses (Part III)
$250,724

Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Functional expenses

Part IX, the statement of functional expenses.

  • 11g · Fees: other

    total $250,724 · program services $250,724

Mission and programs · 2023

Mission

To oversee, coordinate and support the Pediatric Oncology Programs at Boston Children's Hospital and Dana-Farber Cancer Institute, Inc.

  • Dana-Farber/Children's Hospital Cancer Care, Inc. ("DF/CHCC") is a Massachusetts charitable corporation organized on December 14, 2000, whose members are The Children's Hospital Corporation ("Children's") and Dana-Farber Cancer Institute, Inc. ("Dana-Farber"). Its primary purpose is to oversee, coordinate and support the Pediatric Oncology Program (the "Joint Program"). It also, formalizes the pediatric oncology partnership that has existed between Dana-Farber and Boston Children's since 1947.The Joint Program, which is the largest pediatric oncology program in New England and one of the most active in the country, offers the combined expertise of both a world-class cancer center and an internationally renowned children's hospital. Neighboring institutes connected by pedestrian bridges, Dana-Farber Cancer Institute and Boston Children's Hospital work together to offer seamless, integrated care for children with all types of cancer and blood disorders including the rarest and most complex cases. Through our joint partnership, Dana-Farber/Boston Children's offers more specialists, more treatment options, and more clinical trials than almost any other pediatric center treating cancer and blood disorders in the world.Our Expertise in Treating Pediatric Cancer and Blood Disorders: Our hematologists and oncologists are among the world leaders in their respective specialties; many have pioneered treatments that have been adopted by medical communities around the globe. Our doctors also collaborate with teams of expert subspecialists to provide truly comprehensive care for our patients. Innovative Approaches:Our history of research and innovation has resulted in many of the diagnostic and therapeutic techniques currently used around the world to treat cancer and blood disorders. Today, we continue to stand among the world's leaders in many innovative approaches.Our research, clinical trials, and state-of-the art treatment facilities allow our care teams to provide the safest and most effective care possible.Some of our innovative approaches include:- The Advancing Childhood Cancer Therapies (ACCT) Clinic offers clinical trials for relapsed and refractory cancer. CAR T-cell therapy is a promising new treatment for some of the most challenging cases we face in pediatric leukemia and lymphoma. - Gene therapy delivers DNA into a patient's cells to replace faulty or missing genes or to add new genes in an attempt to cure a disease or make changes so the body is better able to fight off disease. - Immunotherapy is the treatment of disease by inducing, enhancing, or suppressing an immune response. Cancer immunotherapy attempts to stimulate the immune system to reject or destroy tumors.- MIBG therapy is a special treatment for children with refractory or relapsed neuroblastoma. We are one of only a handful of centers in the United States equipped for this type of treatment. - Our Pediatric Cancer Genetic Risk Program provides cancer risk assessment and comprehensive recommendations for managing cancer risk. We also conduct research into many aspects of cancer risk and its management.- Precision medicine allows doctors to tailor treatment to the specific genetic characteristics of a patient's cancer. Dana-Farber/Boston Children's is involved in one of the country's most comprehensive precision cancer medicine initiatives.Conditions we treat: Utilizing proven treatment protocols and innovative therapies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center treats over 100 forms of cancer and blood disorders in children and young adults, including:- Blood Disorders - Our Blood Disorders Center provides comprehensive care for a wide range of non-malignant blood disorders including anemia, hemophilia, myelodysplastic syndrome, sickle cell disease and thalassemia. - Brain Tumors - The specialists in our Brain Tumor Center have the expertise to treat a wide range of malignant brain tumors, including atypical teratoid rhabdoid tumor (AT/RT), diffuse pontine glioma and germ cell tumors of the brain.- Leukemia, Lymphoma, and Histiocytosis - The specialists in our Hematologic Malignancies Center are world leaders in the treatment of pediatric leukemia and lymphoma as well as the primary types of histiocytosis.- Solid Tumors - Our Solid Tumor Center provides advanced treatment, including surgery, for a wide range of solid tumors, including bone tumors like osteosarcoma, soft tissue tumors, neuroblastoma, kidney tumors and liver tumors. - Other Conditions We Treat - The specialists at Dana-Farber/Boston Children's also participate in the care of children and teens with a variety of conditions that do not come under the umbrella of cancers or blood disorders. These other conditions include genetic immunodeficiencies, metabolic disorders, vascular anomalies, and cardiovascular diseases such as pulmonary hypertension and pulmonary vein stenosis.

    Expenses $250,724

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Kevin Churchwell MD

    Trustee

    Total calculated
    $3,197,892
    From this org
    $0
    From related orgs
    $3,062,633
    Other
    $135,259
    Hours/week
    1 + 55 related

    Schedule J breakdown matched by us

    Base
    $0 + $1,575,560 related
    Bonus
    $0 + $927,675 related
    Other
    $0 + $559,398 related
    Deferred
    $0 + $29,700 related
    Nontaxable benefits
    $0 + $105,559 related
    Filer's total
    $0 + $3,197,892 related
  • Laurie Glimcher MD

    Trustee

    Total calculated
    $2,459,825
    From this org
    $0
    From related orgs
    $2,105,144
    Other
    $354,681
    Hours/week
    1 + 50 related

    Schedule J breakdown matched by us

    Base
    $0 + $1,413,095 related
    Bonus
    $0 + $540,784 related
    Other
    $0 + $151,265 related
    Deferred
    $0 + $336,307 related
    Nontaxable benefits
    $0 + $18,374 related
    Filer's total
    $0 + $2,459,825 related
  • Gary Fleisher MD

    Trustee

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Stephen Karp

    Trustee

    Total calculated
    $0
    Hours/week
    1 + 5 related
  • Andrew J Janower

    Trustee

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Robert Smith

    Chair & Trustee

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Laura Wood DNP MS RN

    Trustee

    Total calculated
    $1,079,714
    From this org
    $0
    From related orgs
    $1,005,064
    Other
    $74,650
    Hours/week
    1 + 55 related

    Schedule J breakdown matched by us

    Base
    $0 + $673,992 related
    Bonus
    $0 + $199,386 related
    Other
    $0 + $131,686 related
    Deferred
    $0 + $29,700 related
    Nontaxable benefits
    $0 + $44,950 related
    Filer's total
    $0 + $1,079,714 related
  • Nancy Gibson

    Trustee

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Brad Lucas

    Trustee

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Karen Linde Packman

    Trustee (END TERM 10/16/23)

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Doug Vanderslice

    Treasurer

    Total calculated
    $1,684,195
    From this org
    $0
    From related orgs
    $1,604,073
    Other
    $80,122
    Hours/week
    1 + 55 related

    Schedule J breakdown matched by us

    Base
    $0 + $902,247 related
    Bonus
    $0 + $353,818 related
    Other
    $0 + $348,008 related
    Deferred
    $0 + $29,700 related
    Nontaxable benefits
    $0 + $50,422 related
    Filer's total
    $0 + $1,684,195 related
  • Scott Armstrong MD

    President

    Total calculated
    $900,813
    From this org
    $0
    From related orgs
    $819,691
    Other
    $81,122
    Hours/week
    1 + 50 related

    Schedule J breakdown matched by us

    Base
    $0 + $632,226 related
    Bonus
    $0 + $121,650 related
    Other
    $0 + $65,815 related
    Deferred
    $0 + $46,440 related
    Nontaxable benefits
    $0 + $34,682 related
    Filer's total
    $0 + $900,813 related
  • Lisa Diller MD

    Chief Medical Officer

    Total calculated
    $604,817
    From this org
    $0
    From related orgs
    $549,768
    Other
    $55,049
    Hours/week
    1 + 50 related

    Schedule J breakdown matched by us

    Base
    $0 + $437,781 related
    Bonus
    $0 + $87,655 related
    Other
    $0 + $24,332 related
    Deferred
    $0 + $46,440 related
    Nontaxable benefits
    $0 + $8,609 related
    Filer's total
    $0 + $604,817 related
  • Krietta Bowens Jones

    Clerk

    Total calculated
    $340,050
    From this org
    $0
    From related orgs
    $277,636
    Other
    $62,414
    Hours/week
    1 + 50 related

    Schedule J breakdown matched by us

    Base
    $0 + $276,871 related
    Bonus
    $0 + $77 related
    Other
    $0 + $688 related
    Deferred
    $0 + $25,127 related
    Nontaxable benefits
    $0 + $37,287 related
    Filer's total
    $0 + $340,050 related

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 4b · Supplemental nonqualified retirement plan

Answered no

  • 4a · Severance or change-of-control payment
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Part I, Line 4b
Children's Hospital Corporation and Dana-Farber Cancer Institute, related organizations, made contributions to the supplemental non-qualified retirement plan for the individuals listed below. Contribution amounts are generally based on a percentage of compensation. Participants of the supplemental executive retirement plan are fully vested. All payments with respect to a participant's separation from service will be made in a single sum following the separation from service unless participant has elected to receive the accrued interest portion of his or her account in three annual installments. Contributions were for Children's Hospital Corporation or Dana-Farber Cancer Institute employee benefits and not for Dana-Farber/Children's Hospital Cancer Care, Inc. Trustee or Officer of the Board services and/or responsibilities. During calendar year 2023, Children's Hospital Corporation and Dana-Farber Cancer Institute made contributions to the supplemental non-qualified reitrement plans for the individuals below: Kevin Churchwell, MD received a contribution of $482,116 Laurie Glimcher, MD received a contribution of $136,433 Douglas Vanderslice received a contribution of $246,666 Laura Wood, DNP, MS, RN received a contribution of $97,485 Scott Armstrong, MD received a contribution of $38,700 Lisa Diller, MD received a contribution of $14,194

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2023
Filed
12 August 2025
IRS schema version
2023v6.0
Source object
202542259349302494

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.